| Bioactivity | PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM). PCSK9-IN-27 reduces LDLR degradation and increases LDL-C uptake[1]. |
| Formula | C22H23ClN6O |
| Molar Mass | 422.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gavin Donal O’MAHONY, et al. Pcsk9 inhibitors and methods of use thereof. Patent. WO2024062089A1 |